history of glp 1 drugs Continued growth for GLP-1 receptor agonists and SGLT-2 inhibitors in 2017 of GLP-1RAs approved for the
Description
It consists of 41 items assessing the core psychopathology of eating disorders across four subscales (Restraint, Eating Concern, Shape Concern, and Weight Concern)
Marston issued a ruling clarifying the types of claims allowed under MDL 3094
N Engl J Med 2021;385:1451-61
Now, researchers are exploring new iterations, including oral versions and multi-pathway therapies
One such company that is looking to do so is Altimmune
What the Study Measured Researchers evaluated orforglipron in adults with obesity and in people living with type 2 diabetes
